Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature

Neuromyelitis optica (NMO) is associated with antibodies to aquaporin-4 (termed NMO-IgG or AQP4-Ab) in 60-90% of cases. Little is known about the aetiology of NMO in NMO-IgG/AQP4-Ab negative patients. Here we report on CV2/CRMP5 antibodies in a 69-year-old male patient with NMO-IgG/AQP4-Ab negative...

Full description

Saved in:
Bibliographic Details
Main Authors: Jarius, Sven (Author) , Wildemann, Brigitte (Author)
Format: Article (Journal)
Language:English
Published: 2012
In: Clinical neurology and neurosurgery
Year: 2011, Volume: 114, Issue: 4, Pages: 331-335
ISSN:1872-6968
DOI:10.1016/j.clineuro.2011.10.048
Online Access:Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0303846711003660
Verlag, Volltext: http://dx.doi.org/10.1016/j.clineuro.2011.10.048
Get full text
Author Notes:S. Jarius, K. P. Wandinger, K. Borowski, W. Stoecker, B. Wildemann

MARC

LEADER 00000caa a2200000 c 4500
001 158005742X
003 DE-627
005 20230427065641.0
007 cr uuu---uuuuu
008 180815r20122011xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clineuro.2011.10.048  |2 doi 
035 |a (DE-627)158005742X 
035 |a (DE-576)51005742X 
035 |a (DE-599)BSZ51005742X 
035 |a (OCoLC)1341016975 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Jarius, Sven  |e VerfasserIn  |0 (DE-588)1054615918  |0 (DE-627)791654818  |0 (DE-576)410367478  |4 aut 
245 1 0 |a Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease  |b case report and review of the literature  |c S. Jarius, K. P. Wandinger, K. Borowski, W. Stoecker, B. Wildemann 
264 1 |c 2012 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 3 December 2011 
500 |a Gesehen am 15.08.2018 
520 |a Neuromyelitis optica (NMO) is associated with antibodies to aquaporin-4 (termed NMO-IgG or AQP4-Ab) in 60-90% of cases. Little is known about the aetiology of NMO in NMO-IgG/AQP4-Ab negative patients. Here we report on CV2/CRMP5 antibodies in a 69-year-old male patient with NMO-IgG/AQP4-Ab negative NMO. The association of CV2/CRMP5-Ab with prostate cancer suggests a paraneoplastic aetiology of NMO in our patient. Our report strengthens the case of antibodies other than AQP4-Ab being involved in the immunopathogenesis in a subset of patients with NMO. We conclude that CV2/CRMP5-Ab should be included in the differential diagnosis of NMO, in particular if AQP4-Ab are negative and irrespective of whether a tumour is known or not. We recommend that recombinant tests, which are increasingly used because of their higher sensitivity and specificity, should always be accompanied by standard indirect immunofluorescence employing brain tissue sections in order to avoid CV2/CRMP5-Ab or other paraneoplastic antibodies being overlooked. In addition, we provide a comprehensive review of all patients with CV2/CRMP5-Ab and NMO-like disease published in the English literature so far. 
534 |c 2011 
650 4 |a Aquaporin-4 antibody 
650 4 |a CRMP5 antibody 
650 4 |a CV2 antibody 
650 4 |a Longitudinally extensive transverse myelitis 
650 4 |a Neuromyelitis optica (Devic syndrome) 
650 4 |a NMO-IgG 
650 4 |a Optic neuritis 
650 4 |a Paraneoplastic neurological disorders 
650 4 |a Prostate cancer 
700 1 |a Wildemann, Brigitte  |e VerfasserIn  |0 (DE-588)110203844  |0 (DE-627)510150004  |0 (DE-576)171831330  |4 aut 
773 0 8 |i Enthalten in  |t Clinical neurology and neurosurgery  |d Amsterdam [u.a.] : Elsevier Science, 1974  |g 114(2012), 4, Seite 331-335  |h Online-Ressource  |w (DE-627)320438236  |w (DE-600)2004613-3  |w (DE-576)261862197  |x 1872-6968  |7 nnas  |a Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease case report and review of the literature 
773 1 8 |g volume:114  |g year:2012  |g number:4  |g pages:331-335  |g extent:5  |a Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease case report and review of the literature 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0303846711003660  |x Verlag  |3 Volltext 
856 4 0 |u http://dx.doi.org/10.1016/j.clineuro.2011.10.048  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20180815 
993 |a Article 
994 |a 2012 
998 |g 110203844  |a Wildemann, Brigitte  |m 110203844:Wildemann, Brigitte  |d 910000  |d 911100  |e 910000PW110203844  |e 911100PW110203844  |k 0/910000/  |k 1/910000/911100/  |p 5  |y j 
998 |g 1054615918  |a Jarius, Sven  |m 1054615918:Jarius, Sven  |d 910000  |d 911100  |e 910000PJ1054615918  |e 911100PJ1054615918  |k 0/910000/  |k 1/910000/911100/  |p 1  |x j 
999 |a KXP-PPN158005742X  |e 3022381433 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"title":[{"title_sort":"Clinical neurology and neurosurgery","subtitle":"official publication of the Netherlands Society of Neurology and the Netherlands Society of Neurosurgery and the Flemish Society of Neurology","title":"Clinical neurology and neurosurgery"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"note":["Gesehen am 04.02.20"],"id":{"zdb":["2004613-3"],"eki":["320438236"],"issn":["1872-6968"]},"origin":[{"publisher":"Elsevier Science","dateIssuedDisp":"1974-","dateIssuedKey":"1974","publisherPlace":"Amsterdam [u.a.]"}],"part":{"pages":"331-335","volume":"114","text":"114(2012), 4, Seite 331-335","year":"2012","extent":"5","issue":"4"},"disp":"Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease case report and review of the literatureClinical neurology and neurosurgery","pubHistory":["Nachgewiesen 77.1974 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"320438236"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"given":"Sven","role":"aut","family":"Jarius","display":"Jarius, Sven"},{"given":"Brigitte","family":"Wildemann","display":"Wildemann, Brigitte","role":"aut"}],"recId":"158005742X","id":{"doi":["10.1016/j.clineuro.2011.10.048"],"eki":["158005742X"]},"origin":[{"dateIssuedDisp":"2012","dateIssuedKey":"2012"}],"name":{"displayForm":["S. Jarius, K. P. Wandinger, K. Borowski, W. Stoecker, B. Wildemann"]},"note":["Available online 3 December 2011","Gesehen am 15.08.2018"],"title":[{"subtitle":"case report and review of the literature","title":"Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease","title_sort":"Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease"}],"language":["eng"],"physDesc":[{"extent":"5 S."}]} 
SRT |a JARIUSSVENANTIBODIES2012